U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.03.03 Silver Spring, MD 20993 www.fda.gov January 10, 2019 Shenzhen Mindray Bio-Medical Electronics Co., LTD Jiang Haosen Engineer of Technical Regulation Keji 12th Road South, Hi-tech Industrial Park Shenzhen, Guangdong 518057 CHINA Re: K182636 Trade/Device Name: DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: December 26, 2018 Received: December 28, 2018 Dear Jiang Haosen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
27
Embed
January 10, 2019 Shenzhen Mindray Bio-Medical Electronics ... · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.03.03 Silver Spring, MD 20993 January 10,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
U.S. Food & Drug Administration10903 New Hampshire Avenue D o c I D # 0 4 0 1 7 . 0 3 . 0 3 Silver Spring, MD 20993 www.fda.gov
January 10, 2019
Shenzhen Mindray Bio-Medical Electronics Co., LTD Jiang Haosen Engineer of Technical Regulation Keji 12th Road South, Hi-tech Industrial Park Shenzhen, Guangdong 518057 CHINA
Re: K182636 Trade/Device Name: DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: December 26, 2018 Received: December 28, 2018
Dear Jiang Haosen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
K182636 - Jiang Haosen Page 2
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([email protected]) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
forRobert A. Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
System:Transducer:
Intended Use:
General(Track 1Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal P P P P P P Note 1, 2,3,4,6,7Abdominal P P P P P P P Note 1, 2,3,4,6,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric P P P P P P Note 1,2,4,7Small Organ (Specify**) P P P P P P Note 1,2,4,7,8Neonatal Cephalic P P P P P P P Note 1, 2,4,6,7Adult Cephalic P P P P P P P Note 1, 2,4,6,7Trans-rectal P P P P P P Note 1, 2,3,4,6,7Trans-vaginal P P P P P P Note 1, 2,3,4,6,7Trans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) P P P P P P Note 1,2,4,7,8
Musculo-skeletal(Superficial) P P P P P P Note 1, 2,4,7,8
IntravascularCardiac Adult P P P P P P P Note 1, 2,4,5,6,7, 9Cardiac Pediatric P P P P P P P Note 1, 2,4,5,6,7, 9Intravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel P P P P P P P Note 1, 2,4,6,7Other (Specify***) N N N N N N Note 1, 2,4,7
N=new indication P=previously cleared by FDA E=added under Appendix E
Clinical Application Mode of Operation
Fetal Imaging &Other
Cardiac
Peripheralvessel
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Note 2: Smart3D
Note 3:4D(Real-time 3D)
Diagnostic Ultrasound Indications For Use Format
N/ADC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Prescription USE (Per 21 CFR 801.109)
Note9: Contrast imaging(contrast agent for LVO)
*Intraoperative includes abdominal, thoracic, and vascular
**Small organ-breast, thyroid, testes.
***Other use includes Urology.
Note 4: iScape
Note5: TDI
Note6: Color M
Note7: Biopsy Guidance
Note8: Elastography
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
3C5ASystem:Transducer:Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal P P P P P P Note 1, 2, 4,6,7Abdominal P P P P P P Note 1, 2, 4,6,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel P P P P P P Note 1, 2, 4,6,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Peripheralvessel
3C5ADiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Cardiac
Note9: Contrast imaging(contrast agent for LVO)
*Intraoperative includes abdominal, thoracic, and vascular etc.
Clinical Application Mode of Operation
Fetal Imaging &Other
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D
Concurrence of CDRH, Office of Device Evaluation(ODE)Prescription USE (Per 21 CFR 801.109)
Note 4: iScape Note 3:4D(Real-time 3D)
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
**Small organ-breast, thyroid, testes. ***Other use includes Urology.
Note5: TDI Note6: Color M Note7: Biopsy Guidance Note8: Elastography
6C2System:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal P P P P P P Note 1, 2, 4,6,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal Cephalic P P P P P P Note 1, 2, 4,6,7Adult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac Pediatric P P P P P P Note 1, 2, 4,6,7Intravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel P P P P P P Note 1, 2, 4,6,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System6C2Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application
**Small organ-breast, thyroid, testes. ***Other use includes Urology.
Fetal Imaging &Other
Cardiac
Note8: Elastography
Concurrence of CDRH, Office of Device Evaluation(ODE)
Note7: Biopsy Guidance
Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Note5: TDI Note6: Color M
Mode of Operation
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Note 3:4D(Real-time 3D) Note 4: iScape
*Intraoperative includes abdominal, thoracic, and vascular etc.
7L4ASystem:Transducer:Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal P P P P P P Note 1, 2, 4,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric P P P P P P Note 1, 2, 4,7Small Organ (Specify**) P P P P P P Note 1, 2, 4,7,8Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) P P P P P P Note 1, 2, 4,7,8
Musculo-skeletal(Superficial) P P P P P P Note 1, 2, 4,7,8
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel P P P P P P Note 1, 2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Mode of Operation
Fetal Imaging &Other
Cardiac
Concurrence of CDRH, Office of Device Evaluation(ODE)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System7L4ADiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Note5: TDI
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Note 3:4D(Real-time 3D)
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology.
Note 2: Smart3D
Clinical Application
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Note6: Color M Note7: Biopsy Guidance Note8: Elastography
Note 4: iScape
Note9: Contrast imaging(contrast agent for LVO)
L14-6NESystem:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominalIntra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric P P P P P P Note 1, 2, 4,7Small Organ (Specify**) P P P P P P Note 1, 2, 4,7,8Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) P P P P P P Note 1, 2, 4,7,8
Musculo-skeletal(Superficial) P P P P P P Note 1, 2, 4,7,8
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel P P P P P P Note 1,2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Cardiac
Peripheralvessel
L14-6NEDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Concurrence of CDRH, Office of Device Evaluation(ODE)
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology.
Note6: Color M
Note 3:4D(Real-time 3D) Note 4: iScape
Note 2: Smart3D
Note5: TDI
Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Prescription USE (Per 21 CFR 801.109)
Note7: Biopsy Guidance Note8: Elastography
Clinical Application
Fetal Imaging &Other
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
V11-3System:Transducer:Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal P P P P P P Note 1, 2, 4,6,7AbdominalIntra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectal P P P P P P Note 1, 2, 4,6,7Trans-vaginal P P P P P P Note 1, 2, 4,6,7Trans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***) N N N N N N Note 1, 2, 4,6,7
N=new indication P=previously cleared by FDA E=added under Appendix EAdditional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
V11-3Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Note5: TDI Note6: Color M Note7: Biopsy Guidance Note8: Elastography
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Mode of Operation
*Intraoperative includes abdominal, thoracic, and vascular etc.
Note9: Contrast imaging(contrast agent for LVO)
Note 3:4D(Real-time 3D) Note 4: iScape
Note 2: Smart3D
Concurrence of CDRH, Office of Device Evaluation(ODE)
Clinical Application
Fetal Imaging &Other
Cardiac
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
**Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
V11-3BSystem:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal P P P P P P Note 1, 2, 4,6,7AbdominalIntra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectal P P P P P P Note 1, 2, 4,6,7Trans-vaginal P P P P P P Note 1, 2, 4,6,7Trans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***) N N N N N N Note 1, 2, 4,6,7
N=new indication P=previously cleared by FDA E=added under Appendix EAdditional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Mode of Operation
**Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D
Note5: TDI Note6: Color M Note7: Biopsy Guidance Note8: Elastography
Note 3:4D(Real-time 3D) Note 4: iScape
Clinical Application
Fetal Imaging &Other
Cardiac
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
*Intraoperative includes abdominal, thoracic, and vascular etc.
P4-2System:Transducer:Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal P P P P P P P Note 1, 2,4,6,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult Cephalic P P P P P P P Note 1, 2,4,6,7Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac Adult P P P P P P P Note 1, 2,4,5,6,7, 9Cardiac Pediatric P P P P P P P Note 1, 2,4,5,6,7, 9Intravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Mode of Operation
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
**Small organ-breast, thyroid, testes. ***Other use includes Urology.
Concurrence of CDRH, Office of Device Evaluation(ODE)
Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note7: Biopsy Guidance Note8: Elastography
Cardiac
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D
Note5: TDI Note6: Color M
Note 3:4D(Real-time 3D) Note 4: iScape
*Intraoperative includes abdominal, thoracic, and vascular etc.
Clinical Application
Fetal Imaging &Other
Prescription USE (Per 21 CFR 801.109)
P7-3System:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal P P P P P P P Note 1, 2,6Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal Cephalic P P P P P P P Note 1, 2,6Adult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac Pediatric P P P P P P P Note 1, 2,5,6Intravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Note5: TDI
Note 3:4D(Real-time 3D) Note 4: iScape
Note7: Biopsy Guidance Note6: Color M
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D
Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
Clinical Application
Fetal Imaging &Other
Cardiac
Peripheralvessel
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemP7-3Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation
Prescription USE (Per 21 CFR 801.109)
D7-2ESystem:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal P P P P P P Note 1, 2, 3, 4, 6Abdominal P P P P P P Note 1, 2, 3, 4, 6Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemD7-2EDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Note 2: Smart3D Note 3:4D(Real-time 3D)
Mode of Operation
Note6: Color M Note7: Biopsy Guidance
Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
Note8: Elastography
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology.
Clinical Application
Fetal Imaging &Other
Cardiac
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Note5: TDI
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Note 4: iScape
CW5sSystem:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
N=new indication P=previously cleared by FDA E=added under Appendix E
Note 2: Smart3D
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Clinical Application
Fetal Imaging &Other
Mode of Operation
Cardiac
Peripheralvessel
Note7: Biopsy Guidance
Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Note 3:4D(Real-time 3D)
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes.
Note5: TDI Note6: Color M
Note 4: iScape
***Other use includes Urology.
CW5s
Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)Prescription USE (Per 21 CFR 801.109)
CW2sSystem:Transducer:
Intended Use:
General (Track1 Only) Specific (Track 1 & 3) B M PWD CWD Color
N=new indication P=previously cleared by FDA E=added under Appendix E
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes.
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Note6: Color M
CW2sDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation
Note7: Biopsy Guidance
Peripheralvessel
Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
Note 4: iScape Note5: TDI
Clinical Application
Fetal Imaging &Other
Cardiac
Prescription USE (Per 21 CFR 801.109)
***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D)
C6-2System:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal N N N N N N Note 1, 2, 4,6,7Abdominal N N N N N N Note 1, 2, 4,6,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel N N N N N N Note 1, 2, 4,6,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Note 2: Smart3D Note 3:4D(Real-time 3D) Note 4: iScape Note5: TDI Note6: Color M
Prescription USE (Per 21 CFR 801.109)Concurrence of CDRH, Office of Device Evaluation(ODE)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note7: Biopsy Guidance Note8: Elastography
Cardiac
Peripheralvessel
Clinical Application Mode of Operation
Fetal Imaging &Other
C6-2Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Note9: Contrast imaging(contrast agent for LVO)
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents.
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
L9-3ESystem:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal N N N N N N Note 1,2, 4,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric N N N N N N Note 1,2, 4,7Small Organ (Specify**) N N N N N N Note 1,2, 4,7,8Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) N N N N N N Note 1,2, 4,7,8
Musculo-skeletal(Superficial) N N N N N N Note 1,2, 4,7,8
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel N N N N N N Note 1,2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
**Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D) Note 4: iScape Note5: TDI
L9-3E
*Intraoperative includes abdominal, thoracic, and vascular etc.
Concurrence of CDRH, Office of Device Evaluation(ODE)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of Operation
Fetal Imaging &Other
Cardiac
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note6: Color M
L14-6WESystem:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal N N N N N N Note 1,2, 4,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric N N N N N N Note 1,2, 4,7Small Organ (Specify**) N N N N N N Note 1,2, 4,7, 8Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) N N N N N N Note 1,2, 4,7,8
Musculo-skeletal(Superficial) N N N N N N Note 1,2, 4,7,8
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel N N N N N N Note 1,2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Note6: Color M Note7: Biopsy Guidance Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)
Concurrence of CDRH, Office of Device Evaluation(ODE)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D) Note 4: iScape Note5: TDI
Cardiac
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes.
Prescription USE (Per 21 CFR 801.109)
Peripheralvessel
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemL14-6WEDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of OperationClinical Application
Fetal Imaging &Other
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
L13-3System:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal N N N N N N Note 1, 2, 4,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric N N N N N N Note 1, 2, 4,7Small Organ (Specify**) N N N N N N Note 1,2, 4,7, 8Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) N N N N N N Note 1, 2, 4,7,8
Musculo-skeletal(Superficial) N N N N N N Note 1, 2, 4,7,8
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel N N N N N N Note 1, 2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
**Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D)
Concurrence of CDRH, Office of Device Evaluation(ODE)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
Note 4: iScape Note5: TDI Note6: Color M
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemL13-3Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of OperationClinical Application
*Intraoperative includes abdominal, thoracic, and vascular etc.
Peripheralvessel
Prescription USE (Per 21 CFR 801.109)
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Fetal Imaging &Other
Cardiac
7L4BSystem:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal N N N N N N Note 1, 2, 4,7Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric N N N N N N Note 1, 2, 4,7Small Organ (Specify**) N N N N N N Note 1, 2, 4,7Neonatal CephalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional) N N N N N N Note 1, 2, 4,7
Musculo-skeletal(Superficial) N N N N N N Note 1, 2, 4,7
IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vessel N N N N N N Note 1, 2, 4,7Other (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Prescription USE (Per 21 CFR 801.109)
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Mode of OperationClinical Application
Fetal Imaging &Other
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound System
Note 4: iScape Note5: TDI
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B.
Cardiac
Peripheralvessel
7L4B
Note6: Color M Note7: Biopsy Guidance
*Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes. ***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D)
Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
DE10-3ESystem:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetal N N N N N N Note 1, 3, 4, 6,7AbdominalIntra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatricSmall Organ (Specify**)Neonatal CephalicAdult CephalicTrans-rectal N N N N N N Note 1, 3, 4, 6,7Trans-vaginal N N N N N N Note 1, 3, 4, 6,7Trans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac AdultCardiac PediatricIntravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Prescription USE (Per 21 CFR 801.109)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemDE10-3EDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of OperationClinical Application
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B. *Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes.
Fetal Imaging &Other
Cardiac
Peripheralvessel
Concurrence of CDRH, Office of Device Evaluation(ODE)
***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D) Note 4: iScape Note5: TDI Note6: Color M Note7: Biopsy Guidance Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
P10-4ESystem:Transducer:Intended Use:
General (Track1 Only)
Specific (Track 1 & 3)B M PWD CWD Color
DopplerAmplitude
DopplerCombined(specify) Other (specify)
Ophthalmic OphthalmicFetalAbdominal N N N N N N N Note 1, 2,4,6Intra-operative (Specify*)Intra-operative (Neuro)LaparoscopicPediatric N N N N N N N Note 1, 2,4,6Small Organ (Specify**)Neonatal Cephalic N N N N N N N Note 1, 2,4,6Adult Cephalic N N N N N N N Note 1, 2,4,6Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)IntravascularCardiac Adult N N N N N N N Note 1, 2,4,5,6Cardiac Pediatric N N N N N N N Note 1, 2,4,5,6Intravascular (Cardiac)Trans-esoph. (Cardiac)Intra-cardiacPeripheral vesselOther (Specify***)
N=new indication P=previously cleared by FDA E=added under Appendix E
Prescription USE (Per 21 CFR 801.109)
DC-60/DC-60S/DC-60 Exp/DC-55 Diagnostic Ultrasound SystemP10-4EDiagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of OperationClinical Application
Additional comments Combined modes--B+M PW+B Color + B Power + B PW +Color+ B Power + PW +B. *Intraoperative includes abdominal, thoracic, and vascular etc. **Small organ-breast, thyroid, testes.
Fetal Imaging &Other
Cardiac
Peripheralvessel
***Other use includes Urology. Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. Note 2: Smart3D Note 3:4D(Real-time 3D) Note 4: iScape Note5: TDI Note6: Color M Note7: Biopsy Guidance Note8: Elastography Note9: Contrast imaging(contrast agent for LVO)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)Concurrence of CDRH, Office of Device Evaluation(ODE)
B-1
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in
accordance with the requirements of SMDA 1990 and 21 CFR §807.92(c).
1. Submitter:
Shenzhen Mindray Bio-medical Electronics Co., LTD
Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Shenzhen,
Guangdong, 518057, P. R. China
Tel: +86 755 8188 6183
Fax: +86 755 2658 2680
Contact Person:
Jiang Haosen
Shenzhen Mindray Bio-medical Electronics Co., LTD
Mindray Building, Keji 12th Road South, Hi-tech Industrial Park,